Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
Compensation Framework Study
First Interim Report
Second Interim Report
The Inquiry Report
Publication Day
Evidence
Evidence
Hearings Archive
Compensation
Support
Confidential Psychological Support
Interim Payments
Support Groups
Get in touch
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
Michael Palmer informed Susan Deacon, that officials had already written to SNBTS, Department of Health and haemophilia clinicians in Scotland requesting detailed information on events raised by Margaret Smith MSP on 6 August 1999, and provided a draft reply from the Minister to Margaret Smith MSP.
Published on:
31 July, 2024
Susan Deacon told the Inquiry how at this point she had to examine properly what had happened in the 1980s around heat treatment and wished to set out the facts "as best we could in the public domain."
Published on:
31 July, 2024
Susan Deacon's office advised that discussions around compensation were very much a PR exercise and it was unlikely to ever be paid. In her oral evidence, Susan Deacon refuted using these words herself.
Published on:
31 July, 2024
Michael Palmer, Dr Keel, Lynda Towers and Sandra Falconer met Professor Ian Franklin of SNBTS and Drs Robert Perry and Ron McIntosh of PFC to discuss the investigation of circumstances surrounding the safety of SNBTS blood products from Hepatitis C.
Published on:
31 July, 2024
Fax from Jane Kelly of PFC to Mike Palmer at the Department of Health, Scottish Office, including a document titled Factor VIII Concentrates manufactured by SNBTS (1974-1999).
Published on:
31 July, 2024
Background Notes on the Development of Hepatitis-Safe Factor 8 concentrates were produced by SNBTS.
Published on:
31 July, 2024
Michael Palmer wrote to the SNBTS National Director regarding the investigation of circumstances surrounding the safety of SNBTS blood products from Hepatitis C.
Published on:
31 July, 2024
Dr Robert Perry wrote to Michael Palmer providing Background Notes on the Development of Hepatitis-Safe Factor VIII Concentrate by SNBTS.
Published on:
31 July, 2024
Professor Lowe and Professor Ludlam confirmed that it was normal practice within their centres to inform patients of the result of a test if they were found to be HCV positive.
Published on:
31 July, 2024
A briefing note from Michael Palmer to Susan Deacon, Minister for Health and Community Care, recommended that she emphasise to the Haemophilia Society that the Health Department was at arm's length from SNBTS, and that the Health Department aimed to report on its investigations within a month, with the Scottish Executive issuing its conclusions as soon as possible thereafter.
Published on:
31 July, 2024
Susan Deacon, Minister for Health and Community Care, assured the Haemophilia Society that issues raised by the Society would be investigated.
Published on:
31 July, 2024
Michael Palmer's report of the meeting on 14 September 1999 described how it became clear during the meeting that there were other strands of inquiry which the Haemophilia Society wished the Scottish Executive to pursue in its investigation, including the information provided to patients by clinicians. He reported that the Minister, Susan Deacon, assured the Society that these issues would also be investigated, although this would take longer than the expected month.
Published on:
31 July, 2024
First Minister of Scotland, Donald Dewar, expressed concern about the potential financial exposure should compensation for infection with Hepatitis C be paid.
Published on:
31 July, 2024
The Haemophilia Society expressed concern that some patients had been tested for Hepatitis C and not told the results and that in many cases there was delay in being told.
Published on:
31 July, 2024
Following a meeting with the Haemophilia Society Susan Deacon widened the Scottish Executive investigation to consider what information was provided to patients.
Published on:
31 July, 2024
An email sent by Karen Jackson on behalf of Donald Dewar expressed concern about the financial exposure to the Government of compensation payments.
Published on:
31 July, 2024
Susan Deacon's office advised that the matter was a PR exercise and compensation was unlikely to be paid.
Published on:
31 July, 2024
Karin Pappenheim wrote to Susan Deacon expressing the hope that communication between the Minister and the Haemophilia Society would continue and emphasised the importance of impartiality.
Published on:
31 July, 2024
The Scottish Executive investigation was expanded to consider information given to patients about the risks of contracting Hepatitis C/non-A non-B Hepatitis and the alleged delay in informing people with haemophilia that they were Hepatitis C positive after they had been tested.
Published on:
31 July, 2024
It was the expectation, as communicated to the Haemophilia Society, that the necessary evidence relating to the investigation would be examined within a month.
Published on:
31 July, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2031
Page
2032
Page
2033
Page
2034
Current page
2035
Page
2036
Page
2037
Page
2038
Page
2039
…
Next page
Next
Last page
Last